journal
Journals European Respiratory Review : ...

European Respiratory Review : An Official Journal of the European Respiratory Society

https://read.qxmd.com/read/37993126/investigating-the-prognostic-value-of-digital-mobility-outcomes-in-patients-with-chronic-obstructive-pulmonary-disease-a-systematic-literature-review-and-meta-analysis
#41
REVIEW
Sara C Buttery, Parris J Williams, Saeed M Alghamdi, Keir E J Philip, Alexis Perkins, Constantinos Kallis, Jennifer K Quint, Michael I Polkey, Sofie Breuls, Joren Buekers, Nikolaos Chynkiamis, Laura Delgado-Ortiz, Heleen Demeyer, Anja Frei, Judith Garcia-Aymerich, Elena Gimeno-Santos, Sarah Koch, Dimitrios Megaritis, Ashley Polhemus, Thierry Troosters, Ioannis Vogiatzis, Henrik Watz, Nicholas S Hopkinson
BACKGROUND: Reduced mobility is a central feature of COPD. Assessment of mobility outcomes that can be measured digitally (digital mobility outcomes (DMOs)) in daily life such as gait speed and steps per day is increasingly possible using devices such as pedometers and accelerometers, but the predictive value of these measures remains unclear in relation to key outcomes such as hospital admission and survival. METHODS: We conducted a systematic review, nested within a larger scoping review by the MOBILISE-D consortium, addressing DMOs in a range of chronic conditions...
December 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37993125/molecular-monitoring-of-lung-allograft-health-is-it-ready-for-routine-clinical-use
#42
REVIEW
Pauline Pradère, Andrea Zajacova, Saskia Bos, Jérôme Le Pavec, Andrew Fisher
Maintenance of long-term lung allograft health in lung transplant recipients (LTRs) requires a fine balancing act between providing sufficient immunosuppression to reduce the risk of rejection whilst at the same time not over-immunosuppressing individuals and exposing them to the myriad of immunosuppressant drug side-effects that can cause morbidity and mortality. At present, lung transplant physicians only have limited and rather blunt tools available to assist them with this task. Although therapeutic drug monitoring provides clinically useful information about single time point and longitudinal exposure of LTRs to immunosuppressants, it lacks precision in determining the functional level of immunosuppression that an individual is experiencing...
December 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37914194/association-of-preserved-ratio-impaired-spirometry-with-mortality-a-systematic-review-and-meta-analysis
#43
REVIEW
Shuyuan Yang, Gengze Liao, Lap Ah Tse
BACKGROUND: Preserved ratio impaired spirometry (PRISm) is prevalent within the general population. Increased mortality has been reported among subjects with PRISm, but the evidence has never been summarised. This systematic review aims to synthesise evidence on the association between PRISm and the risk of all-cause, cardiovascular and respiratory-related mortality. METHODS: We systematically searched MEDLINE, Embase and Web of Science for population-based cohort studies from inception to April 2023 using the terms related to impaired spirometry and mortality...
December 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37914193/self-management-interventions-for-people-with-pulmonary-fibrosis-a-scoping-review
#44
REVIEW
Joanna Y T Lee, Gabriella Tikellis, Leona Dowman, Arwel W Jones, Mariana Hoffman, Christie R Mellerick, Carla Malaguti, Yet H Khor, Anne E Holland
BACKGROUND: The most effective method for encouraging self-management in individuals with pulmonary fibrosis (PF) is unclear. This review aimed to identify common self-management components, the outcome measures used and the impact of these components in PF. METHODS: A scoping review was conducted according to the Joanna Briggs Institute Manual for Evidence Synthesis using Medline, Embase, PsychInfo, CINAHL and the Cochrane Central Register of Controlled Trials...
December 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37914192/the-re-emerging-role-of-linoleic-acid-in-paediatric-asthma
#45
REVIEW
Sarah Naughten, Gertrude Ecklu-Mensah, Gailan Constantino, Alessandro Quaranta, Keriann Schulkers Escalante, Shiyu Bai-Tong, Jack Gilbert, Sandra Leibel, Craig E Wheelock, Sydney Leibel
Asthma is the most common chronic disease within the paediatric population. Although it is multifactorial, its onset may be linked to early-life exposures with subsequent impact on immune system development. Microbial and dietary metabolic products have been implicated in the development and exacerbation of paediatric asthma. Linoleic acid is the most common omega-6 polyunsaturated fatty acid in the Western diet. In this review, we summarise the literature regarding the involvement of linoleic acid in the development of and its impact on existing paediatric asthma...
December 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37852660/ergonomics-of-bronchoscopy-good-advice-or-a-pain-in-the-neck
#46
REVIEW
Prince Ntiamoah, Michael Machuzak, Thomas R Gildea, Atul C Mehta
Interventional pulmonologists require a unique set of skills including precise motor abilities and physical endurance, but surprisingly the application of ergonomic principles in the field of bronchoscopy remains limited. This is particularly intriguing when considering the significant impact that poor ergonomics can have on diagnostic aptitude, income potential and overall health. It is therefore imperative to provide comprehensive education to physicians regarding the significance of ergonomics in their work, especially considering the introduction of advanced diagnostic and therapeutic procedures...
December 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37852659/montelukast-in-paediatric-asthma-and-allergic-rhinitis-a-systematic-review-and-meta-analysis
#47
REVIEW
Karina Mayoral, Catalina Lizano-Barrantes, Víctor Zamora, Angels Pont, Carme Miret, Cristina Barrufet, M Araceli Caballero-Rabasco, Manuel Praena-Crespo, Alberto Bercedo, Laura Valdesoiro-Navarrete, Maria Teresa Guerra, Yolanda Pardo, Mª José Martínez Zapata, Olatz Garin, Montse Ferrer
BACKGROUND: We aim to assess the impact of montelukast on paediatric patients with asthma/allergic rhinitis, measured using patient-reported outcome measures, compared with other treatments or placebo. METHODS: Protocol registration CRD42020216098 (www.crd.york.ac.uk/PROSPERO). MEDLINE and Embase databases were used to conduct the search. Two authors independently selected studies and extracted data, and a third reviewer resolved discrepancies. Meta-analyses were constructed to estimate the standardised mean difference (SMD) using a random-effects model...
December 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37852658/systematic-review-of-ceftaroline-fosamil-in-the-management-of-patients-with-methicillin-resistant-staphylococcus-aureus-pneumonia
#48
REVIEW
Antoní Torres, Alona Kuraieva, Gregory G Stone, Catia Cillóniz
Methicillin-resistant Staphylococcus aureus (MRSA) is responsible for an array of problematic community- and healthcare-acquired infections, including pneumonia, and is frequently associated with severe disease and high mortality rates. Standard recommended treatments for empiric and targeted coverage of suspected MRSA in patients with community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP), are vancomycin and linezolid. However, adverse events such as acute kidney injury and Clostridium difficile infection have been associated with these antibiotics...
December 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37852657/how-inhaled-corticosteroids-target-inflammation-in-copd
#49
REVIEW
Simon Lea, Andrew Higham, Augusta Beech, Dave Singh
Inhaled corticosteroids (ICS) are the most commonly used anti-inflammatory drugs for the treatment of COPD. COPD has been previously described as a "corticosteroid-resistant" condition, but current clinical trial evidence shows that selected COPD patients, namely those with increased exacerbation risk plus higher blood eosinophil count (BEC), can benefit from ICS treatment. This review describes the components of inflammation modulated by ICS in COPD and the reasons for the variation in response to ICS between individuals...
December 31, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37758276/lost-in-translation-a-neglected-mtor-target-for-lymphangioleiomyomatosis
#50
REVIEW
Jilly F Evans, Francis X McCormack, Nahum Sonenberg, Vera P Krymskaya
Lymphangioleiomyomatosis (LAM) is a cystic lung disease of women resulting from mutations in tuberous sclerosis complex (TSC) genes that suppress the mammalian target of rapamycin complex 1 (mTORC1) pathway. mTORC1 activation enhances a plethora of anabolic cellular functions, mainly via the activation of mRNA translation through stimulation of ribosomal protein S6 kinase (S6K1)/ribosomal protein S6 (S6) and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1)/eukaryotic translation initiation factor 4E (eIF4E)...
September 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37758275/sarcoidosis-associated-pulmonary-fibrosis-joining-the-dots
#51
REVIEW
Debabrata Bandyopadhyay, Mehdi S Mirsaeidi
Sarcoidosis is a multisystem granulomatous disorder of unknown aetiology. A minority of patients with sarcoidosis develop sarcoidosis-associated pulmonary fibrosis (SAPF), which may become progressive. Genetic profiles differ between patients with progressive and self-limiting disease. The mechanisms of fibrosis in SAPF are not fully understood, but SAPF is likely a distinct clinicopathological entity, rather than a continuum of acute inflammatory sarcoidosis. Risk factors for the development of SAPF have been identified; however, at present, it is not possible to make a robust prediction of risk for an individual patient...
September 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37758274/methods-to-assess-copd-medications-adherence-in-healthcare-databases-a-systematic-review
#52
REVIEW
Delphine Vauterin, Frauke Van Vaerenbergh, Anna Vanoverschelde, Jennifer K Quint, Katia Verhamme, Lies Lahousse
BACKGROUND: The Global Initiative for Chronic Obstructive Lung Disease 2023 report recommends medication adherence assessment in COPD as an action item. Healthcare databases provide opportunities for objective assessments; however, multiple methods exist. We aimed to systematically review the literature to describe existing methods to assess adherence in COPD in healthcare databases and to evaluate the reporting of influencing variables. METHOD: We searched MEDLINE, Web of Science and Embase for peer-reviewed articles evaluating adherence to COPD medication in electronic databases, written in English, published up to 11 October 2022 (PROSPERO identifier CRD42022363449)...
September 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37758273/neuropsychiatric-events-associated-with-montelukast-in-patients-with-asthma-a-systematic-review
#53
REVIEW
Chris Wai Hang Lo, Swathi Pathadka, Simon Xiwen Qin, Lydia W Y Fung, Vincent Ka Chun Yan, Hei Hang Edmund Yiu, Chloe I Bloom, Ian Chi Kei Wong, Esther Wai Yin Chan
BACKGROUND: The United States Food and Drug Administration issued a black box warning on the mental health adverse effects of montelukast in 2020. Age-related effects on the risk of developing specific neuropsychiatric events in montelukast users remain largely unknown. OBJECTIVE: To describe the risk of neuropsychiatric events associated with montelukast in adults and children with asthma. METHODS: A systematic search of all studies investigating neuropsychiatric events in montelukast users was performed in PubMed, the Cochrane Library and Embase from inception to 7 September 2022...
September 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37758272/stem-cell-therapy-in-pulmonary-hypertension-current-practice-and-future-opportunities
#54
REVIEW
Ruixuan Zheng, Tingting Xu, Xinghong Wang, Lehe Yang, Jian Wang, Xiaoying Huang
Pulmonary hypertension (PH) is a progressive disease characterised by elevated pulmonary arterial pressure and right-sided heart failure. While conventional drug therapies, including prostacyclin analogues, endothelin receptor antagonists and phosphodiesterase type 5 inhibitors, have been shown to improve the haemodynamic abnormalities of patients with PH, the 5-year mortality rate remains high. Thus, novel therapies are urgently required to prolong the survival of patients with PH. Stem cell therapies, including mesenchymal stem cells, endothelial progenitor cells and induced pluripotent stem cells, have shown therapeutic potential for the treatment of PH and clinical trials on stem cell therapies for PH are ongoing...
September 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37758271/atypical-imaging-patterns-during-lung-invasive-mould-diseases-lessons-for-clinicians
#55
REVIEW
Alessio Casutt, Frédéric Lamoth, Olivier Lortholary, John O Prior, Andrea Tonglet, Oriol Manuel, Anne Bergeron, Catherine Beigelman-Aubry
Imaging of pulmonary invasive mould diseases (IMDs), which represents a cornerstone in their work-up, is mainly based on computed tomography (CT). The purpose of this review is to discuss their CT features, mainly those related to aspergillosis and mucormycosis. We will especially focus on atypical radiological presentations that are increasingly observed among non-neutropenic emerging populations of patients at risk, such as those receiving novel anticancer therapies or those in the intensive care unit. We will also discuss the interest of other available imaging techniques, mainly positron emission tomography/CT, that may play a role in the diagnosis as well as evaluation of disease extent and follow-up...
September 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37673427/the-role-of-vaccination-in-copd-influenza-sars-cov-2-pneumococcus-pertussis-rsv-and-varicella-zoster-virus
#56
JOURNAL ARTICLE
Susanne Simon, Oana Joean, Tobias Welte, Jessica Rademacher
Exacerbations of COPD are associated with worsening of the airflow obstruction, hospitalisation, reduced quality of life, disease progression and death. At least 70% of COPD exacerbations are infectious in origin, with respiratory viruses identified in approximately 30% of cases. Despite long-standing recommendations to vaccinate patients with COPD, vaccination rates remain suboptimal in this population. Streptococcus pneumoniae is one of the leading morbidity and mortality causes of lower respiratory tract infections...
September 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37673426/unsupervised-home-spirometry-versus-supervised-clinic-spirometry-for-respiratory-disease-a-systematic-methodology-review-and-meta-analysis
#57
REVIEW
Rohan Anand, Rebecca McLeese, John Busby, Jonathan Stewart, Mike Clarke, William D-C Man, Judy Bradley
BACKGROUND: The number of patients completing unsupervised home spirometry has recently increased due to more widely available portable technology and the COVID-19 pandemic, despite a lack of solid evidence to support it. This systematic methodology review and meta-analysis explores quantitative differences in unsupervised spirometry compared with spirometry completed under professional supervision. METHODS: We searched four databases to find studies that directly compared unsupervised home spirometry with supervised clinic spirometry using a quantitative comparison ( e...
September 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37673425/effects-of-continuous-positive-airway-pressure-therapy-on-glucose-metabolism-in-patients-with-obstructive-sleep-apnoea-and-type-2-diabetes-a-systematic-review-and-meta-analysis
#58
REVIEW
Jonas Herth, Noriane Adriana Sievi, Felix Schmidt, Malcolm Kohler
Obstructive sleep apnoea is a highly prevalent chronic disorder and has been shown to be associated with disturbed glucose metabolism and type 2 diabetes. However, the evidence from individual clinical trials on the effect of continuous positive airway pressure (CPAP) treatment on glycaemic control in patients with co-existing obstructive sleep apnoea and type 2 diabetes remains controversial. A systematic review of randomised controlled trials assessing the effect of CPAP on glycaemic control in patients with obstructive sleep apnoea and type 2 diabetes was conducted using the databases MEDLINE, Embase, Cochrane and Scopus up to December 2022...
September 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37673424/peripheral-blood-monocyte-count-and-outcomes-in-patients-with-interstitial-lung-disease-a-systematic-review-and-meta-analysis
#59
REVIEW
Bohyung Min, Amanda Grant-Orser, Kerri A Johannson
BACKGROUND: Peripheral blood monocyte counts have been associated with poor outcomes in interstitial lung disease (ILD). However, studies are limited by variable biomarker thresholds, analytic approaches and heterogenous populations. This systematic review and meta-analysis characterised the relationship between monocytes and clinical outcomes in ILD. METHODS: Electronic database searches were performed. Two reviewers screened abstracts and extracted data. Pooled estimates (hazard ratios (HRs)) of monocyte count thresholds were calculated for their association with mortality using ≥0...
September 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
https://read.qxmd.com/read/37611949/-immune-mechanisms-in-fibrotic-pulmonary-sarcoidosis-p-weeratunga-d-r-moller-and-l-p-ho-eur-respir-rev-2022-31-220178
#60
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
September 30, 2023: European Respiratory Review: An Official Journal of the European Respiratory Society
journal
journal
30811
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.